Your browser has javascript turned off or blocked. This will lead to some parts of our website to not work properly or at all. Turn on javascript for best performance.

The browser you are using is not supported by this website. All versions of Internet Explorer are no longer supported, either by us or Microsoft (read more here: https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Please use a modern browser to fully experience our website, such as the newest versions of Edge, Chrome, Firefox or Safari etc.

Default user image.

Daniel Engelbertsen

Assistant researcher

Default user image.

IL-1R and MyD88 signalling in CD4+ T cells promote Th17 immunity and atherosclerosis

Author

  • Daniel Engelbertsen
  • Sara Rattik
  • Maria Wigren
  • Jenifer Vallejo
  • Goran Marinkovic
  • Alexandru Schiopu
  • Harry Björkbacka
  • Jan Nilsson
  • Eva Bengtsson

Summary, in English

The role of CD4+ T cells in atherosclerosis has been shown to be dependent on cytokine cues that regulate lineage commitment into mature T helper sub-sets. In this study, we tested the roles of IL-1R1 and MyD88 signalling in CD4+ T cells in atherosclerosis. Methods and results We transferred apoe-/-myd88\+/\+ or apoe-/-myd88-/- CD4+ T cells to T-A nd B-cell-deficient rag1-/-apoe-/- mice fed high fat diet. Mice given apoe-/-myd88-/- CD4+ T cells exhibited reduced atherosclerosis compared with mice given apoe-/-myd88\+/\+ CD4+ T cells. CD4+ T cells from apoe-/-myd88-/- produced less IL-17 but similar levels of IFN-c. Treatment of human CD4+ T cells with a MyD88 inhibitor inhibited IL-17 secretion in vitro. Transfer of il1r1-/- CD4+ T cells recapitulated the phenotype seen by transfer of myd88-/- CD4+ T cells with reduced lesion development and a reduction in Th17 and IL-17 production compared with wild type CD4+ T cell recipients. Relative collagen content of lesions was reduced in mice receiving il1r1-/- CD4+ T cells. Conclusion We demonstrate that both IL1R and MyD88 signalling in CD4+ T cells promote Th17 immunity, plaque growth and may regulate plaque collagen levels.

Department/s

  • EXODIAB: Excellence in Diabetes Research in Sweden
  • EpiHealth: Epidemiology for Health
  • Cardiovascular Research - Immunity and Atherosclerosis
  • Rausing laboratory of Lund - Tumor section
  • Cardiovascular Research - Cellular Metabolism and Inflammation
  • Surgery (Lund)
  • Department Office of Clinical Sciences, Lund

Publishing year

2018-01-01

Language

English

Pages

180-187

Publication/Series

Cardiovascular Research

Volume

114

Issue

1

Document type

Journal article

Publisher

Oxford University Press

Topic

  • Cardiac and Cardiovascular Systems

Keywords

  • Atherosclerosis
  • IL-1
  • MyD88
  • T cells
  • Th17

Status

Published

Research group

  • Cardiovascular Research - Immunity and Atherosclerosis
  • Rausing laboratory of Lund - Tumor section
  • Cardiovascular Research - Cellular Metabolism and Inflammation

ISBN/ISSN/Other

  • ISSN: 0008-6363